1. | jmc27587 | |
2. | abye7e4l | |
3. | skaterzero | |
4. | shayh41 | |
5. | davidhunt80 |
1. | jmc27587 | |
2. | abye7e4l | |
3. | skaterzero | |
4. | shayh41 | |
5. | davidhunt80 |
1. | abye7e4l 01/30/2018 Weakness in gene therapy names being attributed to circulation of paper that highlights 'Severe toxicity' … |
2. | abye7e4l 01/24/2018 Closing of Public Offering |
3. | skaterzero 01/16/2018 Down over 10% today |
4. | jmc27587 01/30/2018 William Blair reiterates Buy rating |
5. | shayh41 03/27/2018 Awarded Sakigake designation for spinal muscular atrophy type 1 |
6. | jmc27587 01/26/2018 Always back for more shares |
7. | jmc27587 01/18/2018 news link on pricing $102 |
8. | jmc27587 01/30/2018 Announces that, following review of safety data and early signals of efficacy from the first three patients … |
9. | skaterzero 02/28/2018 AveXis Reports Fourth Quarter and Full Year 2017 Financial and Operating Results |
10. | abye7e4l 01/16/2018 News.... Selling 4mil shares |